Search results
AB Science provides an update on the application for conditional marketing authorisation of...
Benzinga· 8 hours agoFR0010557264 - AB) today announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (& ...
EMA Updates Guidance On Inhalation And Nasal Product Quality
BioresearchOnline· 17 hours agoInhalation and nasal medicinal products include pressurized metered-dose inhalers, dry powder...
EC grants orphan status to Rocket Pharma's heart therapy By Investing.com
Investing.com· 5 hours agoThis designation is for the treatment of plakophilin-2 related arrhythmogenic cardiomyopathy...
EMA accepts HLX14 application from Henlius and Organon By Investing.com
Investing.com· 5 days agoDenosumab is utilized for conditions including osteoporosis in postmenopausal women at high risk for fracture. The applications for HLX14, which is under investigation as a biosimilar to the ...
Insmed stocks soar as Phase III lung disease drug exceeds expectations
Clinical Trials Arena via Yahoo Finance· 14 hours agoBrensocatib is being investigated in other neutrophil-driven inflammatory diseases with significant...
How EXO Biologics plans to revolutionize exosome therapy with €16m cash injection
BioPharma-Reporter· 2 days ago“This Series A funding will enable EXO to accelerate the clinical development of our own pipeline...
US lawmakers call for investigations into allegations of Chinese doping before Olympics
KOMU Columbia· 7 hours agoThe Chinese swimmers tested positive for trimetazidine, a banned performance-enhancing substance,...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters via Yahoo News· 5 days agoNovavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 6 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it was pulling the vaccine ...
NLS Pharmaceutics Announces Receipt of Additional Staff Delisting Determination from Nasdaq
StreetInsider· 3 days agoZRICH, SWITZERLAND / ACCESSWIRE / May 24, 2024 / NLS Pharmaceutics Ltd. (NASDAQ: NLSP)(NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical...